Mazloum Ali, Karagyaur Maxim, Chernyshev Roman, van Schalkwyk Antoinette, Jun Ma, Qiang Fu, Sprygin Alexander
Federal Center for Animal Health, Vladimir, Russia.
Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Moscow, Russia.
Front Vet Sci. 2023 Aug 3;10:1180621. doi: 10.3389/fvets.2023.1180621. eCollection 2023.
Gene editing tools have become an indispensable part of research into the fundamental aspects of cell biology. With a vast body of literature having been generated based on next generation sequencing technologies, keeping track of this ever-growing body of information remains challenging. This necessitates the translation of genomic data into tangible applications. In order to address this objective, the generated Next Generation Sequencing (NGS) data forms the basis for targeted genome editing strategies, employing known enzymes of various cellular machinery, in generating organisms with specifically selected phenotypes. This review focuses primarily on CRISPR/Cas9 technology in the context of its advantages over Zinc finger proteins (ZNF) and Transcription activator-like effector nucleases (TALEN) and meganucleases mutagenesis strategies, for use in agricultural and veterinary applications. This review will describe the application of CRISPR/Cas9 in creating modified organisms with custom-made properties, without the undesired non-targeted effects associated with virus vector vaccines and bioactive molecules produced in bacterial systems. Examples of the successful and unsuccessful applications of this technology to plants, animals and microorganisms are provided, as well as an in-depth look into possible future trends and applications in vaccine development, disease resistance and enhanced phenotypic traits will be discussed.
基因编辑工具已成为细胞生物学基础研究中不可或缺的一部分。基于下一代测序技术已产生了大量文献,跟踪这一不断增长的信息库仍然具有挑战性。这就需要将基因组数据转化为切实可行的应用。为了实现这一目标,生成的下一代测序(NGS)数据构成了靶向基因组编辑策略的基础,利用各种细胞机制中的已知酶,来培育具有特定选定表型的生物体。本综述主要聚焦于CRISPR/Cas9技术,相较于锌指蛋白(ZNF)、转录激活样效应因子核酸酶(TALEN)和成簇规律间隔短回文重复序列核酸酶(CRISPR/Cas9)诱变策略,其在农业和兽医应用中的优势。本综述将描述CRISPR/Cas9在创建具有定制特性的改良生物体中的应用,而不会产生与病毒载体疫苗和细菌系统中产生的生物活性分子相关的不良非靶向效应。本文提供了该技术在植物、动物和微生物上成功与失败应用的实例,并深入探讨了疫苗开发、抗病性和增强表型性状方面可能的未来趋势和应用。